Join our daily newsletter At The Bell to receive exclusive market insights
Compumedics (ASX:CPM), a world leader in sleep and neuro diagnostics, is growing as a company, which isn’t surprising when considering the growing prevalence of modern health conditions affecting neuro behaviours like sleep.
For more than three decades, the company has been driving innovation not just here in Australia but across global healthcare, with their technologies used in hospitals, clinics, and research centres worldwide.
With a record breaking year in its rear-view and a promising outlook for FY26, the company is staring down a potential break out period in the market.
Especially so because the company is pivoting into an interesting space: becoming perhaps the first ‘AI Sleep Company’ on the ASX.
Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.
Disclaimer: HotCopper had a commercial relationship with CMP at the time this article was crafted and published.
